TRPV1 vanilloid receptor antagonists with a bicyclic portion
申请人:Pharmeste S.r.l.
公开号:EP2377850A1
公开(公告)日:2011-10-19
The invention discloses compounds of formula I
wherein Y s selected from a group of formula
and W, Q, n, R1, R2, R3, U1-U5 have the meanings given in the description.
The compounds of formula I are TRPV1 antagonists and are useful as active ingredients of pharmaceutical compositions for the treatment of pain and other conditions ameliorated by the inhibition of the vanilloid receptor TRPV1. 1.
[EN] "TRPV1 VANILLOID RECEPTOR ANTAGONISTS WITH A BICYCLIC PORTION"<br/>[FR] ANTAGONISTES DU RÉCEPTEUR VANILLOÏDE TRPV1 AYANT UNE PARTIE BICYCLIQUE
申请人:PHARMESTE SRL
公开号:WO2011120604A1
公开(公告)日:2011-10-06
The invention discloses compounds of formula I wherein Y is a group of formula A, B, C, D, or E: and W, Q, n, R1, R2, R3, U1-U5, J and K have the meanings given in the description. The compounds of formula I are TRPV1 antagonists and are useful as active ingredients of pharmaceutical compositions for the treatment of pain and other conditions ameliorated by the inhibition of the vanilloid receptor TRPV1.